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a b s t r a c t
Background: Gingival overgrowth (GO) is usually associated with multiple factors including immuno-
suppressive agents as cyclosporine (CsA) and Tacrolimus (TAC), and hereditary gingival fibromatosis
(HGF).
Objective: To compare the expression of TGF-b1, PDGF, TIMP-1 and MMP-9 at the molecular and cellular
levels in patients receiving (CsA or TAC) and patients manifested (HGF), to cast some light on the
pathogenic mechanism potentially involved in the collagen (COL) turnover of both conditions.
Subjects: and methods: Gingival tissue samples were obtained from patients undergoing therapy with
CsA (n ¼ 6), TAC (n ¼ 6), HGF (n ¼ 3) as well as control tissues from systemically healthy control (n ¼ 6).
Tissue sections were immune-stained by labeled streptavidin-biotin (DAB) technique, using monoclonal
antibodies against TGF-b1, PDGF-b, TIMP-1 and MMP-9.
Results: comparison of type of expression among the studied groups, showed significant diffuse
expression of TGF-b1 and PDGF-b in group I and II with P value ¼ 0.58 and 0.38 respectively. The
expression of MMP-9 was significantly diffuse in TAC or CsA group when compared to HGF group with P
value ¼ 0.38, mean while there was a significant diffuse expression of TIMP-1 in HGF group when
compared to TAC or CsA group with P value ¼ 0.38.
Conclusions: In conclusion the biological mechanisms behind the drug induced gingival overgrowth
(DIGO) and HGF is targeting COL turnover but in different ways. Also, this may explain the need for
periodic surgical correction of the gingival form and architecture in HGF cases, unlike the DIGO which
can be overcame by replacement of CsA by TAC with improvement of oral health.
© 2016 Faculty of Oral & Dental Medicine, Future University. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
1. Introduction
Gingival overgrowth (GO) is defined as abnormal growth of
maxillary and mandibular gingiva. It may causes aesthetic changes
and clinical symptoms such as pain, speech disturbances, abnormal
tooth movement, dental occlusion problems, enhanced risk of
caries and periodontal disorders [1,2].
Gingival overgrowth is also known as gingival hyperplasia or
gingival fibromatosis, it is usually associated with multiple factors
including inflammation, drug use, neoplasias, hormonal distur-
bances, uncontrolled diabetes and blood dyscrasias [3e5]. In rare
cases (1 in 750,000 people), the overgrowth can be hereditary or
associated with unknown pathogenesis, hence the former are
described as hereditary gingival fibromatosis (HGF) while the
others recognized as idiopathic gingival fibromatosis (IGF) [6,7].
Most HGF cases are probably caused by genetic disorders, and
therefore should not be called idiopathic, usually identified by
significant family history. HGF can occur as isolated disease
affecting only the gingiva or as part of a syndrome or chromosomal
abnormality, transmitted as autosomal dominant trait inwhich two
* Corresponding author. 90th Street, New Cairo, Egypt. Tel.: þ20 2 26701496 or
þ20 1001324032.
E-mail addresses: halaelmenoufy@yahoo.com (H. El-Menoufy), lobna72@gmail.
com (L.A. Aziz Aly), Alyaa_fue@yahoo.com (A. Ragae).
Contents lists available at ScienceDirect
Future Dental Journal
journal homepage: http : / /www.journals .e lsevier .com/locate/ fdj
http://dx.doi.org/10.1016/j.fdj.2016.04.003
2314-7180/© 2016 Faculty of Oral & Dental Medicine, Future University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Future Dental Journal 2 (2016) 28e36
El-Menoufy et al.: Collagen turnover induced by cellular connective tissue cytokines
Published by Arab Journals Platform, 2016
gene loci on the short arm of chromosome 2 where identified in a
Brazilian family [8,9].
Drug induced gingival overgrowth (DIGO) is a side effect and
unwanted outcome of systemic medications and is limited to
gingival tissue. This is most obvious in the cases of organ transplant
recipient who require continuous therapy with immunosuppres-
sive agents, primarily cyclosporine A (CsA), its clinical use is often
complicated by several well documented systemic and oral side
effects. In the last years, Tacrolimus (TAC/FK506) have been intro-
duced as a new immunosuppressive agents, it has been successfully
used as an alternative to CsA with limited systemic and oral side
effects [10,11].
DIGO is a pathology characterized by increased deposition of
extracellular matrix (ECM) components particularly interstitial
collagen (COL), together with altered (COL) turnover may be the
main switch for (GO) development [12,13].
In HGF, the histological characteristics suggest that the expan-
sion of gingival tissue results mostly from increased ECM accu-
mulation, since the tissue is rich in collagen, associated with
relatively few fibroblasts. In addition to increased proliferation of
epithelial cells may account for the formation of elongated rete
pegs [14].
It is well known, that (ECM) is an important regulation to cell
functions, and it also serves as storage for various growth factors
and participates in the regulation of their activation. Thus, altered
abundance or composition of ECM may play an active part in the
pathogenesis of GO in both HGF and DIGO [15,16].
In addition, the content of the interstitial collagen 1 (COL-1)
which is themajor components of ECM ismainly determined by the
finely tuned balance between synthesis and degradation mediated
bymatrix metalloproteinases (MMPs), which are themetabolism of
extracellular components. Disturbance in the physiological balance
between MMPs and their endogenous serum and tissue inhibitors
of metalloproteinases (TIMPs) is implicated in several inflamma-
tory disorders. The major serum inhibitor is a2-macroglobulin,
which covalently crosslink with and inactivates target MMPs while
tissue inhibitors of MMPs to their active forms. In general, any
derangement in the regulatory mechanism controlling MMPs and
their inhibitors collagen may increase, leading to GO [17e19].
In fact, connective tissue turnover is largely controlled by che-
mokines and cytokines secreted by inflammatory cells such as
macrophages and lymphocytes and to a lesser degree by fibroblasts.
It has been shown that in Go tissues, there are abnormally high
levels of specific cytokines including interleukin-6 (IL-6), (IL-Ib),
Transforming Growth factor (TGF-b1), Platelet Derived Growth
Factor-B (PDGF-B), Fibroblast Growth Factor-2 (FGF-2) and Con-
nective Tissue Growth Factor (CTGF) [20,21].
In this tightly regulated mechanism, TGF-b1 is the major
mediator influencing collagen turnover. There are three isoforms of
TGF-b family (b1, b2, b3) that are expressed in humans to stimulate
fibroblast proliferation and deposition of ECM, it also regulate
various functions of epithelial cells, including cell migration, pro-
liferation and gene expression. The functions of different isoforms
are distinct, since TGF-b1 and TGF-b2 are involved in the devel-
opment of fibrosis, while TGF-b3 appears to prevent it. Almost all
human cells synthesize TGF-b1and have receptors for it, alpha
granules of platelets and macrophages are the most concentrated
source of TGF-b1 [22,23].
Platelet derived growth factor (PDGF) is a dimeric polypeptides
consisting of A and B chains, in homodimer (AA,BB) or heterodimer
(AB) combinations. The A chain is believed to play a minor role in
cell proliferation and tissue repair, while the B chain act as a potent
mitogen for cells of mesenchymal origin. Additionally, it has been
demonstrated that PDGF-B is both mitogenic and chemotactic for
periodontal ligament cells in vitro. It is a major chemoattractant for
fibroblasts stimulating fibroblasts proliferation and synthesis of
glycosamine-glycans, proteoglycans, fibronectin and collagen.
PDGF-B is released from platelets, macrophage, endothelial cells
and fibroblasts. In terms of proliferative activity, the release of
tissue proliferation associated with fibroblast activity. Thus, its
increased level in gingival tissue may be responsible for fibroblast
proliferation and/or fibroblast production of extracellular matrix
constituents in hyperplastic tissues [24,25].
Up to now, no detailed in vivo study has investigated and
compares the difference in cellular and molecular components of
the gingival connective tissue (CT) of both DIGO due to immuno-
suppressive agents and HGF. Therefore, we sought to analyze and
compare the expression of TGF-b1, PDGF-b, MMP-9 and TIMP-1 at
the molecular and cellular levels in the gingival connective tissue of
patients receiving immunosuppressive agents (CsA or TAC) as well
as patients manifested HGF, to cast some light on the pathogenic
mechanisms potentially involved in the collagen turnover of both
conditions.
2. Subjects and methods
The present study was conducted between Jan 2012and Dec
2014. The study populations were grouped into three groups:
group I (HGF gp) consisted of three females' patients (2 sisters and
their mother) was brought to the department of periodontology of
Misr University for Science and Technology with the chief
complaint of a slow growing, non tender gingival enlargement.
There was no history of epilepsy or long term medication for any
ailments. Group II (TAC gp and CsA gp) consisted of twelve male
patients aged between (40e55years), having undergone liver
transplantation at the hospital of Ain Shams University, Wadi-
ElNeal Hospital and liver transplantation center of El Maadi Mili-
tary Hospital. 6 patients taking TAC while the other 6 patients
taking CsA. Finally group III included the healthy controls, selected
from the outpatient clinic of Future University, and they were free
from any systemic illness and receiving nomedications for at least 6
months prior to any investigations. As regard patients of group II,
they were at least 6 months with no graft rejection; none of them
received multiple transplantations, and their liver function tests
were stable.
Smokers, those treated with hydantoin, nifedipine, amlodipine,
verapamil and diltiazem and/or with associated systemic diseases
that could have a known effect on the gingival tissues such as
thrombocytopenic purpura, leukemia or diabetes mellitus were
excluded from the study. All patients of group II were required to
have at least 10 anterior teeth. All patients were willing to partic-
ipate in the research after being informed about the nature of the
study and all written forms and consents were explained to the
patient and signed accordingly. Our research has been conducted in
full accordance with the World Medical Association Declaration of
Helsinki of 1975, as revised in 2000, and the study has been inde-
pendently reviewed and approved by an ethics committee review
board at Future University.
Patients and controls received full mouth scaling and in-
structions upon oral hygiene measures, gingival tissue samples
were not harvested until complete subsidence of inflammation as
recorded by the gingival and plaque indices [26,27]. The gingival
overgrowth was assessed using the scale established by Sasaki
et al., [28] and the selected patients showed scale [2,3] or [4].
paraffin embedded gingival samples were obtained from all
groups and paraffin embedded tissue blocks were cut into 4e6
micron thick, tissue sections were stained with Haematoxylin and
Eosin for histopathological examination of all studied cases.
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2.1. Immunohistochemistry for tissue specimens
Fixed tissue sections of all the studied cases were immuno-
stained by using labeled streptavidin-biotin (DAB) according to
Hsu et al. [29] using monoclonal antibodies for TGF-b1, PDGF-B,
TIMP and (MMP-9).
2.1.1. TGF-b1 immunostaining
Uno kinase and a-SMA immunohistochemistry was performed
on formalin-fixed, paraffin embedded gingival tissue biopsies by
peroxidase-antiperoxidase technique (Dako), with dia-
minobenzidine as chromogenic substrate. Mouse monoclonal an-
tibodies against human UPA (American Diagnostics, Stanford, CT,
USA) and a-SMA (Sigma) were used. We performed negative con-
trols by replacing primary antibodies with non-immune serum. As
positive controls UPA and a-SMA expression were detected in
migrating epithelial cells from gingival mucosa and submucosa
respectively.
2.1.2. PDGF-B immunostaining
Paraffin embedded 5micron tissue sections were deparaffinized
with xylene, dehydrated in graded series of ethanol and then
incubated with 3% hydrogen peroxide. Slides were rinsed in phos-
phate buffer saline (PBs) then exposed to heat induced epitope for
20 min after cooling, the slides were incubated over night with
anti-PDGF-B monoclonal IgG1 mouse anti-body (Santa Cruz
Biotechnology). Detection of PDGF-B binding was achieved by us-
ing substrate/chromogen (Diaminobenzidine, DAB) reagent. Posi-
tive readings appeared as membrane and cytoplasmic brownish
staining.
2.1.3. TIMP immunostaining
200 mg/ml of antibody purified from ascites fluid by Protein G
chromatography. Prepared in 10mMPBS, pH 7.4, with 0.2% BSA and
0.09% sodium azide.
2.1.4. MMP-9 immunostaining
For all gingival sections, detection MMP-9 was carried out using
the Avidine-Biotine immuno peroxidase polyclonal primary anti-
body for MMP-9 (NeoMarkers, Lab Vision Corporation). Sections
from breast carcinoma þve to MMP-9 were used as þve control.
Whole ve control slides were obtained from the same gingival
blocks and instead of using the primary antibody, non-rabbit
immuno rabbit serum was used.
2.2. Interpretation of the immunoperoxidase staining findings
Sections from gingival tissue of all groups were assessed, as
positive readings appeared as membrane brownish staining for
MMP-9 while membrane and cytoplasmic brownish staining for
TGF-b1, PDGF-B and TIMP as examined by light microscopy power
10:40. The immuno-reactivity was expressed as: () absent, (þ)
weak, (þþ) moderate, and (þþþ) strong. Photographs were taken
by microscope built-in camera using Kodac ASA 100 slide film.
2.3. Statistical analysis
Data obtained were statistically analyzed, tabulated and dis-
cussed. SPSS (Statistical Package for Social Sciences) version 10.0
was used for data analysis. Chi-square and Fisher exact test were




Histological examination of all samples excised from interdental
area of HGF group revealed a fibroconnective tissue with extensive
collagen bundle characterized by the focal hypocellular spindle
cells proliferation and mononuclear inflammatory infiltrated cells
(Fig. 1).
The overlying surface of the epithelium exhibited hyperkerato-
sis only in HGF group (Fig. 2), and a mild thickening in the gingival
epithelium and hyperplastic stratified squamous epithelium with
elongated rete-ridges showing a tubular pattern were observed
compared to drug treated groups (Figs. 3 and 4).
More over some samples, showed degenerative area in the
stratified squamous epithelium and hylanization of the fibrous
tissue which were found to be correlated to the long term
appearance of the lesion (Fig. 4).
On examining the tissues with Masson Trichrome stain for the
detection of collagenous fibers, deep stain where observed in
idiopathic sections compared to drugs sections (Fig. 5).
3.2. Immunohistochemical findings
The comparison of expression (focal and diffuse) of TGF-b1
among the studied groups showing that there was a diffuse
expression of TGF-b1 variable in different groups 70% for idiopathic,
60e80% for CsA, 60% for TAC and 10% for control which was sta-
tistically significant (p value ¼ 0.58) (Fig. 6).
The comparison of the type of expression (focal and diffuse) of
PDGF-b among the studied groups showing that there was a diffuse
expression of PDGF-b variable in different groups 60% for HGF, 70%
for CsA, 60% for TAC and 5% for control which was statistically
significant (p value ¼ 0.38) (Fig. 7).
The comparison of type of expression (focal or diffuse) of TIMP
among the studied groups showing that there was a diffuse
expression of TIMP variable in different groups 80% for HGF, 50% for
CsA, 30e40% for TAC and 10% for control which was statistically
significant (p value ¼ 0.38) (Fig. 8).
The comparison of the type of expression (focal or diffuse) of
MMP-9 among the studied groups showing that there was a diffuse
expression of MMP-9 which was variable in different groups 30%
for HGF, 60e70% for CsA, 60% for TAC and 5% for control which was
statistically significant (P value ¼ 0.38) (Fig. 9).
Fig. 1. Photomicrograph of gingival section of HGF Gp showing bundles of collagen
fibers, aggregation of chronic inflammatory cells (200).
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4. Discussion
Drug therapy by immunosuppressive agents and hereditary
factors are two of the main causes of gingival overgrowth. Both
forms are associated with increased ECM accumulation, also both
conditions are beyond the control of the dental professional, here
the clinical management of GO presents a continuous challenge and
clearly requires the active involvement of both dental and medical
professionals to minimize the possibility of complications
[11,18,30].
The pathogenesis of GO is complex, several factors at the mo-
lecular, cellular, tissue and systemic levels may play relevant roles.
Characterization of these factors is necessary to fully understand
the biological processes underlying this condition [18]. Thus, in
trying to highlight recent advances in the identification of molec-
ular/cellular processes underlying the GO induced by immuno-
suppressive agents currently used to prevent rejection of organ
transplants (kidney or liver) as well as rare cases of Hereditary
overgrowth this study was conducted, in an attempt to continue
the investigations that have been performed concerning this field.
In this study, we sought to analyze and compare the changes in
collagen turnover pathway induced by immunosuppressive drugs
such as (CsA and TAC) as well as changes accompany HGF in the
cellular and molecular levels. As most of the attention to date has
focused on cytokine expression alterations, studies characterizing
the molecular mechanisms responsible for the effect of HGF on
collagen turnover pathway are still lacking maybe because of the
rarity of the cases. Previous studies concerning this issue have only
Fig. 2. Photomicrograph of gingival section showing A) normal keratosis in drug group. B) The overlying surface of the epithelium exhibited hyperkeratosis in HGF group.
Fig. 3. Photomicrograph of gingival section of a,b) HGF Gp showing mild hyperplastic stratified squamous epithelium with elongated rete-ridges showing a tubular pattern. c) CsA
treated group showing pronounced increase in epithelial thickness (hyperplasia) ( ), marked elongation of papillae (P) and hypertrophy of epithelial lining mucosa. d) mild
hyperplasia (E), notable elongation of papillae (P), and mild degenerative areas ( ).
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investigated either the effect of immunosuppressive drugs or the
effect of HGF in a separate investigations [12,14,18].
Actually, there was more attention to the effect of CsA on GO
that have been clearly demonstrated. Hence, in this investigation
we tried also to focus on TAC as well. To our knowledge this
comparative immune-histochemical investigation using this group
of cytokines has been not previously attempted especially among
liver transplant recipients with exclusion of other allograft re-
cipients such as renal transplant recipients, based on previous
studies that have been clearly demonstrated that calcium channel
blockers concurrently used by those patients more specifically
nifedipine, usually presented more sever GO, thus potentiating the
effect of CsA or TAC on the gingival tissue [31,10].
It is well known that healthy gingiva is in a continuous state of
wound repair (cell/tissue turnover) due to constant insult from
bacterial plaque, in which growth factors may play an important
role in this reparative or maintenance process. Within this scenario,
it would be expected to find one or more of the growth factors with
wound repair in normal gingiva. Consequently it might also be
expected to find an elevated level or even an increased number of
growth factors in conditions which involve increased tissue volume
such as drug-induced gingival overgrowth and HGF [32].
Obviously, it is likely that a complex interaction between several
growth factors/cytokines contributes to the clinical presentations
of GO. Although it would be simpler if the drug-induced tissue
response and HGF were specific in nature. Therefore in our study
we selected a group of growth factors and cytokines suspecting
their role in collagen turnover maintenance, either by enhancing
fibroblast proliferation and ECM accumulation represented by TGF-
b1and PDGF-B or by controlling thematrix degradation through the
action of MMP-9 produced by fibroblast as well as TIMP-1. Addi-
tionally, we have not investigated the possible changes in PDGF-A
chain or TGF- b3. As it does not play a major role in connective
tissue proliferation [33,14].
The number of subjects participating in this study was quite
sufficient, to provide a high level of confidence in the generality of
the results obtained. With exception to the group of HGF which is
consisted of two sisters and their mother, indeed we were lucky to
find three relatives as these cases are very rare. All subjects in the
group of DIGO and control group were males as progesterone
decrease glycosaminoglycan synthesis by human gingival fibro-
blasts and suppress GO [34].
In the present work, all tissue samples were harvested after
complete subsidence of inflammation, as inflammatory process
induces alterations in the expression of growth factors and
potentially modifies tissue response [35].
An important limitation in the present study which must be
acknowledged is the lack of a control group consisting of TAC
treated patients not exhibiting gingival overgrowth, as not all
Fig. 4. Photomicrograph of gingival section of HGF Gp showing degenerative area in
the stratified squamous epithelium and hylanization of the fibrous tissue (H).
Fig. 5. Photomicrograph of Masson Trichrome stain for the detection of collagenous fibers, deep stain where observed in idiopathic sections (a) compared to drugs sections (b).
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Fig. 6. Sections of gingival mucosa for (TGF-b) immuno-stained for: (a) HGF group and (b) CsA treated group showing diffuse membranous and cytoplasmic staining, while (c) TAC
treated group showing focal membranous and cytoplasmic staining. (DAB chromogen 200). (d) Comparison of type of expression of TGF-b1 among studied groups.
Fig. 7. Sections of gingival mucosa for (PDGF-B) immuno-stained (a) HGF group and (b) CsA treated group showing diffuse membranous and cytoplasmic staining, while (c) TAC
treated group showing focal membranous and cytoplasmic staining and (d) control group showing ve stain (DAB chromogen 400). (e) Comparison of type of expression of PDGF-
B among studied groups.
Fig. 8. Sections of gingival mucosa for (TIMP) immuno-stained: (a) HGF group showing diffuse membranous and cytoplasmic staining (DAB chromogen 400). (b) Comparison of
type of expression of TIMP among studied groups.
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patients treated with TAC exhibit gingival overgrowth. There have
been great difficulty in obtaining samples from such patients, we
have failed to convince them hoping that future studies could
report data from such samples.
In our work, the histopathological results of HGF cases consis-
tent with the studies of Araujo et al., and Doufexi et al., [36,37]. The
data showed hyperplasia of a dense hyperkeratotic epitheliumwith
elongated rete pegs that penetrate deep in the connective tissue.
The connective tissue in HGF exhibits an accumulation of excess
collagen, as well as elastic and oxytalan fibers, the collagen fibers
are typically organized as thick parallel fiber bundles that are
clearly detected by Masson Trichrome stain showing deep stain
when compared to DIGO group.
Meanwhile, the results of immune-histochemical investigation
of gingival tissue samples of HGF group and CsA group showed
significantly higher diffuse expression of TGF-b1 and PDGF-B, when
compared to TAC group and control one. As in TAC and control
groups the expression of TGF-b1 and PDGF-B is considered focal
expression. This focal expression of TGF-b1 in TAC group is
consistent with the previous studies of Mohammed et al., and
[38,39]. Also, the diffuse expression of TGF-b1 and PDGF-B in CsA
group confirms previous investigations done by Plemons et al.,
Nares et al., and Duncan et al., [25,30,40,41]. In addition, Wright
et al., they confirmed the diffuse expression of TGF-b1 in HGF
samples. The results showed a diffuse expression of MMP-9 in CsA
group and TAC group when compared to focal expression of HGF
and control groups. These data are consistent with the studies of
Gagliano et al., and [42,2] their data showed significant expression
of MMP-1 in human gingival fibroblast treated with CsA or TAC. As
regard the expression of TIMP-1, data demonstrated a significant
diffuse expression in HGF group when compared to DIGO group
and control.
In this regard, the exact molecular and cellular mechanisms
responsible for the above observations are not fully understood at
this time. In fact, the overall picture suggests that ECM is an
important regulator of cell functions, it serves as storage for various
growth factors and participates in the regulation of their activation.
Thus, altered abundance or composition of ECM may play an active
part in the pathogenesis of GO in both DIGO and HGF, characterized
by an accumulation of excess ECM and over production of inter-
stitial collagen, glycosaminoglycan and fibronectin by fibroblast.
Here the role of TGF-b1 in this process is of interest, because
expression of TGF-b1 is upregulated in both HGF and DIGO. In both
conditions it can promote ECM accumulation by increasing ECM
synthesis. It can also inhibit ECM breakdown by down regulating
MMP-9 expression, and by increasing expression of TIMP-1 that
suppress the activity of MMP-9. It is well known that a high ratio of
TIMPs to MMPs results in excess collagen accumulation [43].
Ravanti et al., [44], Leivonen et al., [45] and Ala-aho and Kahari,
[46], demonstrated that exogenous or autocrine TGF-b1 upregu-
lates interstitial collagen (type 1 collagen) and down regulates
MMP-1 expression in gingival fibroblasts. However, it has been
reported that the expression of TIMP-1 and TIMP-2 is down regu-
lated or unaltered in HGF fibroblasts. Thus, it is possible that fi-
broblasts in HGF, inherently or as a response to elevated TGF- b1
activity, produce less MMPs and more ECM proteins as compared
with normal cells, resulting in ECM accumulation. Interestingly,
HGF may also involve altered cross-linking of collagen, resulting in
Fig. 9. Sections of gingival mucosa for (MMP-9) immuno-stained: (a) HGF group and (b) CsA treated group showing diffuse membranous and cytoplasmic staining, while (c) TAC
treated group and (d) control group showing focal membranous and cytoplasmic staining (MMP-9 200). (e) Comparison of type of expression of MMP-9 among studied groups.
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increased resistance to degradation [47].
Collagen phagocytosis by fibroblasts is one of the major mech-
anisms of collagen turnover during tissue maintenance, suggesting
that fibrotic lesions, especially in the absence of inflammation, may
arise from a reduction in the proportion of fibroblasts that degrade
collagen intracellularly [48].
Moreover, the internalization and lysosomal degradation of
collagen by cells in HGF is also mediated by an endocytotic process
that involves the cell-surface receptor Endo 180, which is expressed
by various human gingival cells, including fibroblasts, but its
expression and function in HGF have not been studied in detail [49].
5. Conclusion
In fact, all the above data may contribute to identification of the
molecular and cellular processes leading to the understanding of
the biological mechanisms underlying the overgrowth in both
DIGO and HGF. As it is always gratifying, when an investigation can
provide a possible explanation for clinical observation at the mo-
lecular level, more investigations should be conducted to further
clarify the pathogenic mechanisms potentially involved in the
conditions of DIGO and HGF. We hope that this study might
eventually lead to tangible clinically relevant advances in the field
of periodontology and maxillofacial surgery.
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